Literature DB >> 10678860

Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study.

P Lavie1, P Herer, V Hoffstein.   

Abstract

OBJECTIVE: To assess whether sleep apnoea syndrome is an independent risk factor for hypertension.
DESIGN: Population study.
SETTING: Sleep clinic in Toronto. PARTICIPANTS: 2,677 adults, aged 20-85 years, referred to the sleep clinic with suspected sleep apnoea syndrome. OUTCOME MEASURES: Medical history, demographic data, morning and evening blood pressure, and whole night polysomnography.
RESULTS: Blood pressure and number of patients with hypertension increased linearly with severity of sleep apnoea, as shown by the apnoea-hypopnoea index. Multiple regression analysis of blood pressure levels of all patients not taking antihypertensives showed that apnoea was a significant predictor of both systolic and diastolic blood pressure after adjustment for age, body mass index, and sex. Multiple logistic regression showed that each additional apnoeic event per hour of sleep increased the odds of hypertension by about 1%, whereas each 10% decrease in nocturnal oxygen saturation increased the odds by 13%.
CONCLUSION: Sleep apnoea syndrome is profoundly associated with hypertension independent of all relevant risk factors.

Entities:  

Mesh:

Year:  2000        PMID: 10678860      PMCID: PMC27290          DOI: 10.1136/bmj.320.7233.479

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  10 in total

1.  Population-based study of sleep-disordered breathing as a risk factor for hypertension.

Authors:  T Young; P Peppard; M Palta; K M Hla; L Finn; B Morgan; J Skatrud
Journal:  Arch Intern Med       Date:  1997 Aug 11-25

2.  Snoring as part of a dose-response relationship between sleep-disordered breathing and blood pressure.

Authors:  T Young; L Finn; K M Hla; B Morgan; M Palta
Journal:  Sleep       Date:  1996-12       Impact factor: 5.849

Review 3.  Health effects of obstructive sleep apnoea and the effectiveness of continuous positive airways pressure: a systematic review of the research evidence.

Authors:  J Wright; R Johns; I Watt; A Melville; T Sheldon
Journal:  BMJ       Date:  1997-03-22

4.  Daytime hypertension in obstructive sleep apnea. Prevalence and contributing risk factors.

Authors:  R P Millman; S Redline; C C Carlisle; A R Assaf; P D Levinson
Journal:  Chest       Date:  1991-04       Impact factor: 9.410

Review 5.  Sleep related breathing disorders are common contributing factors to the production of essential hypertension but are neglected, underdiagnosed, and undertreated.

Authors:  D S Silverberg; A Oksenberg; A Iaina
Journal:  Am J Hypertens       Date:  1997-12       Impact factor: 2.689

6.  Mortality in sleep apnea patients: a multivariate analysis of risk factors.

Authors:  P Lavie; P Herer; R Peled; I Berger; N Yoffe; J Zomer; A H Rubin
Journal:  Sleep       Date:  1995-04       Impact factor: 5.849

7.  Sleep apnea and hypertension. A population-based study.

Authors:  K M Hla; T B Young; T Bidwell; M Palta; J B Skatrud; J Dempsey
Journal:  Ann Intern Med       Date:  1994-03-01       Impact factor: 25.391

8.  Natural evolution of snoring: a 5-year follow-up study.

Authors:  K Martikainen; M Partinen; H Urponen; I Vuori; P Laippala; J Hasan
Journal:  Acta Neurol Scand       Date:  1994-12       Impact factor: 3.209

Review 9.  Sleep apnea and systemic hypertension: a causal association review.

Authors:  V Hoffstein; C K Chan; A S Slutsky
Journal:  Am J Med       Date:  1991-08       Impact factor: 4.965

Review 10.  The relationship between systemic hypertension and obstructive sleep apnea: facts and theory.

Authors:  E C Fletcher
Journal:  Am J Med       Date:  1995-02       Impact factor: 4.965

  10 in total
  223 in total

Review 1.  Sleep apnoea and hypertension: proof at last?

Authors:  J R Stradling; J C Pepperell; R J Davies
Journal:  Thorax       Date:  2001-09       Impact factor: 9.139

Review 2.  Are sleep-related breathing disorders important contributing factors to the production of essential hypertension?

Authors:  D S Silverberg; A Oksenberg
Journal:  Curr Hypertens Rep       Date:  2001-06       Impact factor: 5.369

3.  Sleep apnoea and hypertension. Findings cannot be applied to general public.

Authors:  M Harrison; C Jones; E Brabin
Journal:  BMJ       Date:  2000-07-22

4.  Restoring leptin signaling reduces hyperlipidemia and improves vascular stiffness induced by chronic intermittent hypoxia.

Authors:  Ronghua Yang; Gautam Sikka; Jill Larson; Vabren L Watts; Xiaolin Niu; Carla L Ellis; Karen L Miller; Andre Camara; Christian Reinke; Vladimir Savransky; Vsevolod Y Polotsky; Christopher P O'Donnell; Dan E Berkowitz; Lili A Barouch
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-01-28       Impact factor: 4.733

Review 5.  Nitric oxide (NO) and obstructive sleep apnea (OSA).

Authors:  James S J Haight; Per Gisle Djupesland
Journal:  Sleep Breath       Date:  2003-06       Impact factor: 2.816

6.  Sleep and hypertension.

Authors:  David A Calhoun; Susan M Harding
Journal:  Chest       Date:  2010-08       Impact factor: 9.410

Review 7.  Hypoxia-inducible factors and obstructive sleep apnea.

Authors:  Nanduri R Prabhakar; Ying-Jie Peng; Jayasri Nanduri
Journal:  J Clin Invest       Date:  2020-10-01       Impact factor: 14.808

8.  Salivary markers of oxidative stress in patients with obstructive sleep apnea treated with continuous positive airway pressure.

Authors:  L'ubomíra Tóthová; Július Hodosy; Imrich Mucska; Peter Celec
Journal:  Sleep Breath       Date:  2013-12-10       Impact factor: 2.816

9.  Traditional and nontraditional cardiovascular risk factors in comorbid insomnia and sleep apnea.

Authors:  Faith S Luyster; Kevin E Kip; Daniel J Buysse; Aryan N Aiyer; Steven E Reis; Patrick J Strollo
Journal:  Sleep       Date:  2014-03-01       Impact factor: 5.849

10.  Follow-up assessment of CPAP efficacy in patients with obstructive sleep apnea using an ambulatory device based on peripheral arterial tonometry.

Authors:  Stephen D Pittman; Giora Pillar; Richard B Berry; Atul Malhotra; Mary M MacDonald; David P White
Journal:  Sleep Breath       Date:  2006-09       Impact factor: 2.816

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.